These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 29557208

  • 21. Performance and potential clinical impact of Alfred60AST (Alifax®) for direct antimicrobial susceptibility testing on positive blood culture bottles.
    Van den Poel B, Meersseman P, Debaveye Y, Klak A, Verhaegen J, Desmet S.
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):53-63. PubMed ID: 31624985
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method.
    De Angelis G, Posteraro B, Menchinelli G, Liotti FM, Spanu T, Sanguinetti M.
    J Antimicrob Chemother; 2019 Jan 01; 74(Suppl 1):i24-i31. PubMed ID: 30690539
    [Abstract] [Full Text] [Related]

  • 23. Clinical Performance and Impact of Accelerate Pheno for Gram-negative Bacteremia in Hospitalized Children.
    Lee M, Scardina T, Zheng X, Patel SJ.
    Clin Ther; 2020 Sep 01; 42(9):1630-1636. PubMed ID: 32826063
    [Abstract] [Full Text] [Related]

  • 24. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ.
    Clin Ther; 2011 Dec 01; 33(12):1964-73. PubMed ID: 22078154
    [Abstract] [Full Text] [Related]

  • 25. Rapid determination of antimicrobial susceptibility of Gram-negative bacteria from clinical blood cultures using a scattered light-integrated collection device.
    Falconer K, Hammond R, Parcell BJ, Gillespie SH.
    J Med Microbiol; 2024 Feb 01; 73(2):. PubMed ID: 38415707
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009).
    Sader HS, Farrell DJ, Jones RN.
    J Chemother; 2011 Aug 01; 23(4):200-6. PubMed ID: 21803696
    [Abstract] [Full Text] [Related]

  • 27. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program.
    Al Rahmany D, Albeloushi A, Alreesi I, Alzaabi A, Alreesi M, Pontiggia L, Ghazi IM.
    Int J Infect Dis; 2019 Jun 01; 83():77-82. PubMed ID: 30959249
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R, Noriega ER, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2015 Dec 15; 14():53. PubMed ID: 26667651
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
    Balode A, Punda-Polić V, Dowzicky MJ.
    Int J Antimicrob Agents; 2013 Jun 15; 41(6):527-35. PubMed ID: 23590898
    [Abstract] [Full Text] [Related]

  • 33. Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study.
    Zhu Q, Yue Y, Zhu L, Cui J, Zhu M, Chen L, Yang Z, Liang Z.
    Antimicrob Resist Infect Control; 2018 Jun 15; 7():107. PubMed ID: 30202520
    [Abstract] [Full Text] [Related]

  • 34. Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications.
    Giacobbe DR, Giani T, Bassetti M, Marchese A, Viscoli C, Rossolini GM.
    Clin Microbiol Infect; 2020 Jun 15; 26(6):713-722. PubMed ID: 31610299
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2017 Jul 12; 16(1):50. PubMed ID: 28701170
    [Abstract] [Full Text] [Related]

  • 36. Verigene® gram-positive blood culture nucleic acid test.
    Scott LJ.
    Mol Diagn Ther; 2013 Apr 12; 17(2):117-22. PubMed ID: 23345071
    [Abstract] [Full Text] [Related]

  • 37. Using Culture Sensitivity Reports to Optimize Antimicrobial Therapy: Findings and Implications of Antimicrobial Stewardship Activity in a Hospital in Pakistan.
    Altaf U, Saleem Z, Akhtar MF, Altowayan WM, Alqasoumi AA, Alshammari MS, Haseeb A, Raees F, Imam MT, Batool N, Akhtar MM, Godman B.
    Medicina (Kaunas); 2023 Jul 02; 59(7):. PubMed ID: 37512049
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.
    Lutgring JD, Bittencourt C, McElvania TeKippe E, Cavuoti D, Hollaway R, Burd EM.
    J Clin Microbiol; 2018 Apr 02; 56(4):. PubMed ID: 29386262
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Direct identification and susceptibility testing of positive blood cultures using high speed cold centrifugation and Vitek II system.
    Bazzi AM, Rabaan AA, Fawarah MM, Al-Tawfiq JA.
    J Infect Public Health; 2017 Apr 02; 10(3):299-307. PubMed ID: 27312816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.